Infective Endocarditis in North Africa and the Middle East, 1990‒2019: Updates from the Global Burden of Disease Study 2019

Elaheh Malakan Rad,Sara Momtazmanesh,Sahar Saeedi Moghaddam,Negar Rezaei,Nazila Rezaei,Hamidreza Jamshidi,Mohsen Naghavi,Bagher Larijani,Farshad Farzadfar,GBD 2019 NAME Endocarditis Collaborators,Mohsen Abbasi-Kangevari,Zeinab Abbasi-Kangevari,Hedayat Abbastabar,Hassan Abidi,Muhammad Sohail Afzal,Sepideh Ahmadi,Haroon Ahmed,Sami Almustanyir,Jalal Arabloo,Zahra Aryan,Samaneh Asgari,Mohammadreza Azangou-Khyavy,Sara Bagherieh,Akshaya Srikanth Bhagavathula,Ali Bijani,Ahmad Daryani,Muhammed Elhadi,Hossein Farrokhpour,Seyyed-Hadi Ghamari,Ahmad Ghashghaee,Laszlo Göbölös,Mohamad Golitaleb,Mostafa Hadei,Khezar Hayat,Mohammad-Salar Hosseini,Seyed Kianoosh Hosseini,Seyed Sina Naghibi Irvani,Elham Jamshidi,Hamid Reza Koohestani,Savita Lasrado,Ata Mahmoodpoor,Mohammad-Reza Malekpour,Yosef Manla,Ritesh G Menezes,Yousef Mohammad,Paula Moraga,Zuhair S Natto,Fatemeh Pashazadeh Kan,Akram Pourshams,Mohammad Rabiee,Navid Rabiee,Alireza Rafiei,Sima Rafiei,Samira Raoofi,Sina Rashedi,Sahba Rezazadeh-Khadem,Masoumeh Sadeghi,Farhad Saeedi,Abdallah M Samy,Parnian Shobeiri,Soraya Siabani,Majid Taheri,Hamed Tavolinejad,Sahel Valadan Tahbaz,Seyed Hossein Yahyazadeh Jabbari,Mazyar Zahir,Mohammad Zoladl,Hamid Reza Jamshidi

DOI: https://doi.org/10.34172/aim.2024.34

2024-05-01

Abstract:Background: Infective endocarditis (IE), a severe and economically impactful condition, lacks substantial epidemiological data in the North Africa and Middle East (NAME) region. This study focused on analyzing the trends and burden of IE in NAME from 1990 to 2019, taking into account factors like age, gender, and socio-demographic index (SDI). Methods: The Global Burden of Disease data from 1990 to 2019 was retrieved from the Institute for Health Metrics and Evaluation (IHME) website. Results: Between 1990 and 2019, the age-standardized rates (ASR) for IE incidence increased by 59%, and prevalence and years lived with disability (YLDs) rose by 12% and 9%, respectively, while the ASRs for deaths, disability-adjusted life years (DALYs), and years of life lost (YLLs) saw reductions of 22%, 34%, and 34% in the NAME region. Death rates among children under five declined by 72%. Gender and the SDI did not significantly influence these changes. Saudi Arabia witnessed the most significant increase in ASR of IE incidence since 1990, while Turkey had the highest rates in 2019. The year 2019 also saw the highest death rate among those aged 70 and over, with over 91000 DALYs from IE. DALYs decreased by 71.5% for children under five from 1990 to 2019 but remained stable for individuals in their seventies. Jordan showed the most notable decrease in ASRs for deaths, DALYs, and YLLs among children under five. Conclusion: This study highlights the changing epidemiology of IE in the NAME region, recommending the establishment of multidisciplinary IE registries, antibiotic prophylaxis guidelines for healthcare-associated IE, and strategies to control antimicrobial resistance as key mitigation measures.